$30M in gifts to establish Chad Carr Pediatric Brain Tumor Center at the University of Michigan

With support from thousands of supporters across the country, new U-M initiative honoring Chad Carr to advance research and treatment for DIPG and other pediatric brain cancers.

Author | Beata Mostafavi

An incurable brain tumor took Chad Carr’s life when he was just five years old, but now his name will be synonymous with research to fight the lethal pediatric brain cancer.

Multiple donors have committed $30 million to establish the Chad Carr Pediatric Brain Tumor Center at the University of Michigan, an initiative to advance research and treatment for children with brain cancer.

Chad, a grandson of former U-M football coach Lloyd Carr, died in 2015, 14 months after being diagnosed with diffuse intrinsic pontine glioma (DIPG), among the most aggressive and lethal types of brain tumors.

“We are grateful for the generous gifts allowing us to honor Chad through transformational research that will help other children defeat this terrible disease. This is a monumental milestone in our mission to conquer pediatric brain cancer,” says Valerie Opipari, M.D., a pediatric oncologist and chair of the Department of Pediatrics and Communicable Diseases at U-M's C.S. Mott Children’s Hospital. 

“U-M is positioned to lead the search for cures and committed to pushing the limits of what we know about pediatric brain tumors in order to advance science and revolutionize treatment.”

The joint announcement by Michigan Medicine and The ChadTough Foundation is expected to be made at the foundation’s annual Champions for Change Gala on May 19.

“We want to see a day when no family will ever have to suffer this kind of heartbreak,” says Chad’s mom Tammi Carr.

“We believe that the work happening in Chad’s name at the U-M Chad Carr Pediatric Brain Tumor Center will change the future for other children. This is Chad’s legacy.”

Thousands of supporters from across the country came together to raise the $30 million needed to establish and name the center in Chad Carr’s memory. U-M Regent Ron Weiser and Eileen Weiser made lead gifts, along with generous donations from Wayne and Shelly Jones and the Jones Family Foundation, the Glick family and Alro Steel, The ChadTough Foundation, William and Sharon Stein, Frank and Barbara Westover, and David and Joan Evans. Together they have ensured that Chad’s legacy will live on in the transformational research and care at the newly established center.

Brain tumors are the leading cause of death from childhood cancer, and the most dreaded type is DIPG — which stems from the region of the brain that controls vital functions such as breathing and heart rate. Research proves that chemotherapy, radiotherapy and surgery, which together have been the foundation for cancer therapy advances during the last two decades, are not effective against DIPG.

While the field of pediatric cancer research has seen a number of breakthroughs in recent years, DIPG has seen little progress. More than 90 percent of children diagnosed with DIPG die within 18 months of diagnosis. 

U-M’s Chad Carr Pediatric Brain Tumor Center unites experts from multiple specialties, including pediatrics, radiology and neurosurgery, radiation oncology, genetics and pathology as well as engineering and public health to accelerate research on DIPG and other pediatric brain tumors.

“The Chad Carr Pediatric Brain Tumor Center will leverage the breadth and depth of expertise across the university to fuel innovative research and deliver new therapies for children with brain cancer,” says Marschall Runge, M.D., Ph.D., executive vice president for medical affairs at the University of Michigan.

“This incredible collaboration brings together a renowned team of doctors and scientists at Michigan who will pool knowledge and break traditional boundaries to drive advances in research and treatment for pediatric brain cancer.”

Discoveries have already been made by the U-M research team devoted to pediatric brain cancer research, including a study using tissue from Chad’s tumor that uncovered the key and early role of a less-understood genetic mutation in the cancer’s fatal course.

The funds raised are part of a larger $51.5 million campaign to support fundamental scientific research programs on pediatric brain tumors, including DIPG, and develop research strengths and infrastructure to support clinical trials. Philanthropic partnerships are essential for U-M to significantly expand clinical and research capacity in these areas. Only 4 percent of federal funding for cancer research is allocated to pediatric cancers. Brain cancers in children — considered rare by medical statistics — receive just a sliver of that allocation.

“This is a major step toward our goal to improve survival for children with brain cancer, but we have much more work to do,” Opipari says. “We need to continue to build on the incredible momentum that Chad has inspired to find cures.”

Learn more about U-M’s Chad Carr Pediatric Brain Tumor Center at michmed.org/pediatric-brain-tumors.

To support pediatric brain tumor research at U-M, visit: medicine.umich.edu/dept/pediatric-brain-tumor/giving.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]


Featured News & Stories surgeons
Health Lab
Building a sustainable kidney transplant program in Rwanda
A Michigan Medicine surgeon builds a sustainable kidney transplant program in Rwanda.
Health Lab Podcast in brackets with a background with a dark blue translucent layers over cells
Health Lab Podcast
Presenting: The Fundamentals
Today on Health Lab, we are sharing an episode of The Fundamentals, another podcast from the Michigan Medicine Podcast Network that just launched its second season earlier this month. On this episode of The Fundamentals: "Cannabis and psychedelics: stigmatized substances or powerful therapeutics?" Dr. Kevin Boehnke talks about cannabis, psychedelics, and the increasing body of evidence for their legitimization as therapeutics.
weight scale black white in exam room close up
Health Lab
Adding obesity experts to primary care clinics improves patients’ weight loss outcomes
A weight navigation program for primary care patients with obesity led to more use of proven weight management strategies and more weight loss
vials in blue and yellow with syringe
Health Lab
Young people are increasingly using Wegovy and Ozempic
A national study from Michigan Medicine shows that the use of these weight loss drugs is increasing rapidly in adolescents and young adults 12-25 years, especially females.
xray on tablet held by clinician in white coat and stethoscope
Health Lab
These factors are linked to a higher risk of pneumonia after heart surgery
Researchers uncovered nine elements that have significant effects on a whether a patient may develop pneumonia, with nearly 20% of patients moving into a higher risk category based on what occurred during or following the surgery.
provider sitting writing something down with person in khakis and blue shirt unbuttoned with white shirt under
Health Lab
ER screening tool helps identify youth at risk of experiencing firearm violence
A study published by researchers at the University of Michigan reveals that implementing this screening tool can help identify and support youth with firearm violence history.